Morpholino

MO1-fbln1

ID

ZDB-MRPHLNO-121030-1

Name

MO1-fbln1

Previous Names

fbln1-atg-1 (1)

Target

fbln1 (1)

Sequence

5' - ACAACACGATCATGTAGAGATCCAT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Translation-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-fbln1

No data available

Phenotype

Phenotype resulting from MO1-fbln1

No data available

Phenotype of all Fish created by or utilizing MO1-fbln1

Phenotype	Fish	Conditions	Figures
dermis fibrillar collagen trimer disorganized, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 3 from Martins Feitosa et al., 2012
trunk dermis malformed, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 3 from Martins Feitosa et al., 2012
post-vent region integument blistered, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 2 from Martins Feitosa et al., 2012
trunk integument blistered, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 2 , Fig. 3 from Martins Feitosa et al., 2012
dermis fibrillar collagen trimer decreased amount, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 3 from Martins Feitosa et al., 2012
dorsal actinotrichium separated from dorsal fin fold mesenchymal cell, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 5 from Martins Feitosa et al., 2012
skin morphogenesis decreased process quality, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 2 , Fig. 3 from Martins Feitosa et al., 2012
dermis separated from epidermis, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 3 from Martins Feitosa et al., 2012
embryonic medial fin morphogenesis decreased process quality, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 5 from Martins Feitosa et al., 2012
collagen fibril organization decreased process quality, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 3 from Martins Feitosa et al., 2012
dorsal fin fold microfibril disorganized, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 5 from Martins Feitosa et al., 2012
dorsal fin fold mesenchymal cell mislocalised, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 5 from Martins Feitosa et al., 2012
mesenchymal cell migration decreased process quality, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 5 from Martins Feitosa et al., 2012
dorsal fin fold dermis malformed, abnormal	WT + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 5 from Martins Feitosa et al., 2012
median fin fold decreased height, abnormal	sqet37Et + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 4 from Martins Feitosa et al., 2012
embryonic medial fin morphogenesis decreased process quality, abnormal	sqet37Et + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 4 from Martins Feitosa et al., 2012
median fin fold mesenchymal cell decreased branchiness, abnormal	sqet37Et + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 4 from Martins Feitosa et al., 2012
mesenchyme median fin fold mislocalised, abnormal	sqet37Et + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 4 from Martins Feitosa et al., 2012
mesenchymal cell migration decreased process quality, abnormal	sqet37Et + MO1-fbln1 + MO1-hmcn2	standard conditions	Fig. 4 from Martins Feitosa et al., 2012

Citations